The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Epizyme, Inc. Common Stock 29428V104 41,682 3,838,166 SH   SOLE   3,838,166 0 0
Progyny, Inc. Common Stock 74340E103 470,262 11,093,696 SH   SOLE   11,093,696 0 0
Pulmonx Corporation Common Stock 745848101 88,294 1,421,386 SH   SOLE   1,421,386 0 0
TransMedics Group, Inc. Common Stock 89377M109 18,372 932,221 SH   SOLE   932,221 0 0